483 Amphastar Nanjing Pharmaceuticals Apr 2014

483 Amphastar Nanjing Pharmaceuticals Apr 2014

$119 - Not in Stock

FDA investigators audited the Amphastar Nanjing Pharmaceuticals - Nanjing, China facility and issued inspectional observations (via FDA 483) on 04 Apr 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 04 Apr 2014
  • Location: Nanjing, China
  • FEI: 3009805706

Pre-Order Not Available